Evaluation of monkeypox‐ and vaccinia‐virus neutralizing antibodies before and after smallpox vaccination: A sero‐epidemiological study
Journal of Medical Virology · 2024-06 · 96 (6)
DOI: 10.1002/jmv.29728 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 11.06.2024. Verfasst von Serena Marchi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Antibodies, Viral, Smallpox Vaccine, Monkeypox virus. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Since May 2022, several countries outside of Africa experienced multiple clusters of monkeypox virus (MPXV)‐associated disease. In the present study, anti‐MPXV and anti‐vaccinia virus (VACV) neutralizing antibody responses were evaluated in two cohorts of subjects from the general Italian population (one half born before the WHO‐recommended end of smallpox vaccination in 1980, the other half born after). Higher titers (either against MPXV or VACV) were observed in the cohort of individuals born before the interruption of VACV vaccination. An association between VACV and MPXV antibody levels was observed, suggesting that the smallpox vaccination may confer some degree of cross‐protection against MPXV infection. Results from this study highlight low levels of immunity toward the assessed Orthopoxviruses, especially in young adults, advocating the introduction of a VACV‐ or MPXV‐specific vaccine in case of resurgence of monkeypox disease outbreaks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
- VisMederi Srl, Siena, Italy.
- Department of Life Sciences, University of Siena, Siena, Italy.
- Department of Virology, Biomedical Primate Research Centre, Rijswijk, Netherlands.
- Viral Pseudotype Unit, Medway School of Pharmacy, Universities of Kent and Greenwich, Kent, UK.
- VisMederi Research Srl, Siena, Italy.
ORCID-Profile: Serena Marchi, Emanuele Montomoli, Claudia Maria Trombetta
Zitieren
APA
Marchi, S., Piccini, G., Cantaloni, P., Guerrini, N., Zannella, R., Coluccio, R., Benincasa, L., Solfanelli, N., Remarque, E. J., Viviani, S., Kistner, O., Temperton, N., Montomoli, E., Manenti, A., & Trombetta, C. M. (2024). Evaluation of monkeypox‐ and vaccinia‐virus neutralizing antibodies before and after smallpox vaccination: A sero‐epidemiological study. Journal of Medical Virology, 96(6). https://doi.org/10.1002/jmv.29728
Vancouver
Marchi S, Piccini G, Cantaloni P, Guerrini N, Zannella R, Coluccio R, et al. Evaluation of monkeypox‐ and vaccinia‐virus neutralizing antibodies before and after smallpox vaccination: A sero‐epidemiological study. Journal of Medical Virology. 2024;96(6). doi:10.1002/jmv.29728
BibTeX
@article{Marchi2024,
author = {Marchi, Serena and Piccini, Giulia and Cantaloni, Paolo and Guerrini, Noemi and Zannella, Roberta and Coluccio, Rosa and Benincasa, Linda and Solfanelli, Niccolò and Remarque, Edmond J and Viviani, Simonetta and Kistner, Otfried and Temperton, Nigel and Montomoli, Emanuele and Manenti, Alessandro and Trombetta, Claudia Maria},
title = {Evaluation of monkeypox‐ and vaccinia‐virus neutralizing antibodies before and after smallpox vaccination: A sero‐epidemiological study},
journal = {Journal of Medical Virology},
year = {2024},
volume = {96},
number = {6},
doi = {10.1002/jmv.29728}
}
EUVIMED